A

    AngioDynamics Inc (ANGO)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $16.13
    +0.28 (+1.77%)

    Market Cap: $655.12M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    72%(28/39)
    Avg Surprise
    -354.03%
    Streak
    2 Q

    Upcoming Estimates

    Aug 31, 2026
    EPS Consensus$-0.11
    Range$-0.13 - $-0.10
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$-0.10+14.7%
    60d ago$-0.10+14.7%
    30d ago$-0.10+14.7%
    7d ago$-0.10+14.7%
    Current$-0.11
    Revenue Consensus
    $81M
    Range$80M - $81M
    4 analysts
    Nov 30, 2026
    EPS Consensus$-0.08
    Range$-0.10 - $-0.06
    3 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-0.05+43.9%
    60d ago$-0.05+43.9%
    30d ago$-0.05+43.9%
    7d ago$-0.05+43.9%
    Current$-0.08
    Revenue Consensus
    $84M
    Range$82M - $85M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Nov 26EST
    		-$-0.08---
    Aug 26EST
    		-$-0.11---
    May 26
    		$-0.07$-0.11+36.36%Beat-133.3%
    Feb 26
    		$0.02N/A+118.18%Beat-33.3%
    Nov 25
    		$-0.15$-0.10-52.90%Miss-282.3%
    Aug 25
    		$-0.10$-0.12+16.67%Beat+9.1%
    May 25
    		$-0.03N/A+75.00%Beat+50.0%
    Feb 25
    		$0.03N/A+123.08%Beat+118.8%
    Nov 24
    		$-0.04N/A+63.64%Beat+20.0%
    Aug 24
    		$-0.11$-0.15+26.67%Beat+8.3%
    May 24
    		$-0.06N/A+64.71%Beat-400.0%
    Feb 24
    		$-0.16$-0.15-6.67%Miss-433.3%
    Nov 23
    		$-0.05$-0.07+28.57%Beat-600.0%
    Aug 23
    		$-0.12$-0.13+7.69%Beat-100.0%
    May 23
    		$0.02$0.02+0.00%Beat+100.0%
    Feb 23
    		$-0.03$-0.01-200.00%Miss-200.0%
    Nov 22
    		$0.01$-0.01+200.00%Beat+150.0%
    Aug 22
    		$-0.06$-0.02-200.00%Miss-200.0%
    May 22
    		$0.01$0.01+0.00%Beat+102.0%
    Feb 22
    		$0.03$-0.01+400.00%Beat+50.0%
    Nov 21
    		$-0.02$0.01-300.00%Miss-300.0%
    Aug 21
    		$-0.02$-0.04+50.00%Beat-200.0%
    May 21
    		$-0.51$-0.00-15212.12%Miss-742.2%
    Feb 21
    		$0.02$-0.02+200.00%Beat+100.0%
    Nov 20
    		$0.01$-0.02+150.00%Beat-83.3%
    Aug 20
    		$0.02N/A+128.57%Beat-75.0%
    May 20
    		$-0.06$-0.06+0.00%Beat-124.0%
    Feb 20
    		$0.01N/A+133.33%Beat-94.7%
    Nov 19
    		$0.06$0.02+200.00%Beat-72.7%
    Aug 19
    		$0.08$0.04+100.00%Beat-50.0%
    May 19
    		$0.25$0.26-3.85%Miss+25.0%
    Feb 19
    		$0.19$0.22-13.64%Miss-24.0%
    Nov 18
    		$0.22$0.21+4.76%Beat+37.5%
    Aug 18
    		$0.16$0.18-11.11%Miss+33.3%
    May 18
    		$0.20$0.21-4.76%Miss+5.3%
    Feb 18
    		$0.25$0.19+31.58%Beat+31.6%
    Nov 17
    		$0.16$0.16+0.00%Beat-15.8%
    Aug 17
    		$0.12$0.16-25.00%Miss-
    May 17
    		$0.19$0.16+18.75%Beat-
    Feb 17
    		$0.19$0.15+26.67%Beat-
    Nov 16
    		$0.19$0.16+18.75%Beat-

    Key Metrics

    Valuation
    P/E Ratio-53.25EV/EBITDA978.38x
    Price/FCF-181.93xFCF Yield-0.55%
    Profitability
    Profit Margin-11.50%Operating Margin-6.52%
    ROE-20.80%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio2.35xQuick Ratio1.47x
    Trading Statistics
    Beta0.32Avg Volume399.42K
    52-Week High$16.2952-Week Low$9.39

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$15.86
    SMA 20$15.70
    SMA 50$14.40
    SMA 200$12.16
    EMA 10$15.83
    EMA 20$15.55
    EMA 50$14.53
    EMA 200$12.45

    MACD

    Line: 0.45Signal: 0.52Hist: -0.07

    ADX

    ADX: 35.1+DI: 25.9-DI: 12.1

    Aroon & PSAR

    Aroon Up68.0
    Aroon DownN/A
    PSAR$15.42

    Bollinger Bands

    Upper Band$16.27
    Lower Band$15.14
    %B Position722%(Upper)
    Band Width0.88

    RSI (14-Day)

    Neutral
    67.2

    Momentum Oscillators

    Stoch %K65.4
    Stoch %D58.9
    Williams %R-15.0
    ROC (10d)2.9%
    Momentum0.46
    CCI (20d)105.7
    MFI (14d)58.1

    Volatility Measures

    ATR (14d)$0.47(2.9%)
    StdDev (20d)0.28
    Hist Vol20.2%(Moderate)

    Volume Flow

    VWAP$15.99
    OBV8.6M
    AD Line-4.7M
    CMF (20d)0.198

    Volume Metrics

    Avg Vol (20d)380.7K
    Vol Ratio0.9x
    VWMA (20d)$15.66

    Pivot Points

    R3$16.28
    R2$16.12
    R1$15.99
    Pivot Point$15.83
    S1$15.70
    S2$15.54
    S3$15.41

    Advanced Oscillators

    TSI32.47
    Ultimate Osc65.4
    KST126.38

    Financial Data

    QuarterFeb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023Aug 2023May 2023
    Total Revenue$78.42M$79.43M$75.71M$80.16M$72.00M$72.84M$67.49M$70.98M$75.18M$79.07M$78.68M$91.07M
    Cost of Revenue$36.94M$34.65M$33.85M$37.94M$33.15M$32.94M$30.77M$32.47M$39.32M$38.81M$38.62M$44.72M
    Gross Profit$41.48M$44.78M$41.86M$42.22M$38.86M$39.91M$36.72M$38.52M$35.86M$40.26M$40.06M$46.36M
    Operating Expenses$54.43M$50.91M$52.51M$48.01M$48.83M$51.00M$49.82M$52.96M$235.76M$53.38M$5.03M$67.20M
    R&D$7.08M$7.77M$6.42M$6.59M$6.91M$6.43M$6.29M$6.72M$8.19M$8.66M$7.94M$7.86M
    SG&A$10.72M$10.15M$12.55M$10.24M$10.49M$10.39M$10.97M$10.44M$10.58M$9.29M$10.86M$10.23M
    Operating Income$-12,951,000$-6,125,000$-10,656,000$-5,788,000$-9,974,000$-11,094,000$-13,098,000$-14,449,000$-199,896,000$-13,120,000$35.03M$-20,837,000
    Interest Income$-88,000$-102,000$-4,000$3,000$135,000$234,000$606,000$567,000$394,000$534,000$119,000$0
    Interest Expense$0$230,000$182,000$322,000$0$0$0$0$0$0$169,000$1.03M
    Income Before Tax$-8,072,000$-6,355,000$-10,838,000$-6,110,000$-4,409,000$-10,848,000$-12,665,000$-14,141,000$-199,740,000$-12,618,000$34.86M$-21,865,000
    Income Tax Expense$12,000$-5,000$65,000$-60,000$-2,000$-110,000$133,000$-692,000$-12,004,000$16.43M$-11,023,000$-398,000
    Net Income$-8,084,000$-6,350,000$-10,903,000$-6,050,000$-4,407,000$-10,738,000$-12,798,000$-13,449,000$-187,736,000$-29,048,000$45.88M$-21,467,000
    EBITDA$-2,393,000$-506,000$-4,814,000$-280,000$1.77M$-4,219,000$-6,486,000$-7,891,000$-192,612,000$-6,467,000$41.43M$-13,407,000
    EBIT$-7,984,000$-6,253,000$-10,834,000$-6,113,000$-4,544,000$-11,082,000$-13,271,000$-14,708,000$-200,134,000$-13,152,000$34.74M$-20,964,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ANGO

    Government Contracts

    Gov Obligations (TTM)
    -$2434
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter

    A Delaware woman has filed a product liability lawsuit against AngioDynamics, claiming her Xcela port catheter was defectively designed, migrated, and caused infection. The lawsuit alleges that AngioDynamics failed to warn about the risks of migration, fractures, and infections associated with their port catheters. This case joins hundreds of similar AngioDynamics port catheter lawsuits consolidated in federal court, alleging defective designs and inadequate warnings.

    AboutLawsuits.com•8/21/26•
    Bearish

    387,188 Shares in AngioDynamics, Inc. $ANGO Bought by Western Standard LLC

    Western Standard LLC has acquired 387,188 shares of AngioDynamics, Inc. (NASDAQ:ANGO) for approximately $5.04 million, making it their 17th largest position. AngioDynamics recently beat quarterly earnings expectations, reporting a loss of $0.07 per share on $86.61 million in revenue, exceeding estimates despite remaining unprofitable. Analyst sentiment is mixed, with a consensus "Hold" rating and a price target of $19.50.

    MarketBeat•8/20/26•
    Somewhat-Bullish

    AngioDynamics (NASDAQ:ANGO) Reaches New 12-Month High - Still a Buy?

    AngioDynamics (NASDAQ:ANGO) has reached a new 52-week high of $16.25, with mixed analyst ratings including "buy" and "strong sell." Despite beating quarterly earnings and revenue estimates, the company remains unprofitable, and an insider recently sold shares. The consensus rating for ANGO is "Hold" with a $19.50 price target.

    MarketBeat•8/19/26•
    Neutral

    Angiodynamics, Inc. (UG2) Q3 2023 Earnings Report - Results, Call & Slides

    Angiodynamics, Inc. (UG2) reported its Q3 2023 earnings, missing both EPS and revenue expectations. The company posted an actual EPS of -€0.03 against a consensus of >-€0.01, and actual revenue of €69.95M compared to an expected €72.11M, though revenue did show a 9.11% year-over-year growth. An earnings call was held on March 30, 2023, and the next earnings report is estimated for October 1, 2026.

    TipRanks•8/15/26•
    Neutral

    Angiodynamics, Inc. (UG2) Q1 2025 Earnings Report - Results, Call & Slides

    Angiodynamics, Inc. (UG2) released its Q1 2025 earnings report, showing an actual EPS of -€0.10, beating the consensus of -€0.13 by +€0.03. However, the company missed revenue expectations, reporting €58.49M against an expected €58.88M, marking a -14.22% year-over-year decline. The earnings call took place on October 3, 2024, and the next earnings date is estimated for October 1, 2026.

    TipRanks•8/15/26•
    Neutral

    Frequently Asked Questions About ANGO

    Does ANGO pay dividends?
    AngioDynamics Inc (ANGO) does not currently pay a regular dividend.
    What is ANGO's market cap?
    AngioDynamics Inc (ANGO) has a market capitalization of $655.12M with a current stock price of $16.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In